Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$6,429,905
+$726,230 QoQ
Shares Held
25,552
-2.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.24%
of 13F equity value
Holder Rank
#1,159
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Shepherd Financial Partners LLC holds $27,627,511 across 8 Drug Manufacturers - General names. ABBV ranks #2 (23.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,583 | $11,494,138 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
25,552 | $6,429,905 | |
| 3 | MRK |
Merck & Co., Inc.
|
32,703 | $4,202,335 | |
| 4 | JNJ |
Johnson & Johnson
|
11,597 | $2,945,290 | |
| 5 | AMGN |
Amgen Inc
|
4,462 | $1,615,779 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,173 | $400,876 | |
| 7 | PFE |
Pfizer Inc
|
13,337 | $321,154 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,784 | $218,034 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,429,905 | 25,552 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $5,703,675 | 26,225 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $5,969,072 | 26,124 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $6,024,902 | 26,021 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $4,805,330 | 25,888 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,364,131 | 25,602 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $4,466,667 | 25,136 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $4,914,882 | 24,888 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $4,182,515 | 24,385 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $4,402,631 | 24,177 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $3,685,031 | 23,779 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $3,518,412 | 23,604 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,055,676 | 22,680 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,395,855 | 21,308 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $3,436,151 | 21,262 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,872,496 | 21,403 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $3,218,810 | 21,016 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,380,155 | 20,851 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,044,062 | 22,482 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,371,521 | 21,985 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,473,687 | 21,961 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,329,976 | 21,530 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,211,576 | 20,640 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,703,800 | 19,452 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,170,723 | 32,295 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,418,194 | 31,739 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||